COVID-19 Antibodies

Monoclonal & Polyclonal Antibodies to SARS-CoV-2

The antibodies available below have been validated to bind to proteins from SARS-CoV-2 (COVID-19), but were developed originally to target proteins from SARS-CoV-1, the virus responsible for the 2003 outbreak. We are currently developing monoclonal mouse and polyclonal rabbit antibodies specific to SARS-CoV-2 spike and nucleocapsid proteins. The polyclonal antibodies will be available in May. The monoclonal antibodies will be available sometime between July - August.

Western Blot Analysis: 1 µg/ml; Lane M: Protein Marker; Lane 1: N-Protein, 100 ng; Lane 2: 293T cell lysate, 12 µl
Rabbit Anti-SARS-CoV-2 Coronavirus Nucleocapsid Protein

Mouse Anti-SARS-CoV-2 Coronavirus Nucleocapsid protein

Rabbit Anti-SARS-Associated Coronavirus (COVID-19) Spike Protein